S&P 500

5.352,96

-0,02%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Elutia Inc (ELUT)
Elutia Inc (ELUT) Notícias

ELUT

Elutia (ELUT)

Elutia Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ELUT

1

Data	Hora	Fonte	Título	Código	Companhia
13/05/2024	18:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELUT	Elutia Inc
13/05/2024	09:00	GlobeNewswire Inc.	Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024	NASDAQ:ELUT	Elutia Inc
09/05/2024	18:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
09/05/2024	17:05	GlobeNewswire Inc.	Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance	NASDAQ:ELUT	Elutia Inc
02/05/2024	17:05	GlobeNewswire Inc.	Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	NASDAQ:ELUT	Elutia Inc
24/04/2024	17:05	GlobeNewswire Inc.	Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1	NASDAQ:ELUT	Elutia Inc
11/03/2024	10:15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ELUT	Elutia Inc
07/03/2024	18:05	GlobeNewswire Inc.	Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024	NASDAQ:ELUT	Elutia Inc
22/02/2024	18:05	GlobeNewswire Inc.	Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024	NASDAQ:ELUT	Elutia Inc
14/02/2024	18:40	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ELUT	Elutia Inc
25/01/2024	18:56	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ELUT	Elutia Inc
10/01/2024	18:05	GlobeNewswire Inc.	Elutia Regains Compliance with Nasdaq Listing Requirements	NASDAQ:ELUT	Elutia Inc
09/01/2024	18:17	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ELUT	Elutia Inc
08/01/2024	18:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELUT	Elutia Inc
18/12/2023	10:00	GlobeNewswire Inc.	Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance	NASDAQ:ELUT	Elutia Inc
05/12/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ELUT	Elutia Inc
20/11/2023	18:53	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ELUT	Elutia Inc
13/11/2023	18:05	GlobeNewswire Inc.	Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results	NASDAQ:ELUT	Elutia Inc
09/11/2023	10:30	GlobeNewswire Inc.	Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million	NASDAQ:ELUT	Elutia Inc
06/11/2023	18:05	GlobeNewswire Inc.	Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023	NASDAQ:ELUT	Elutia Inc
18/10/2023	09:00	PR Newswire (US)	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update	NASDAQ:ELUT	Elutia Inc
05/10/2023	11:24	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ELUT	Elutia Inc
03/10/2023	12:05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ELUT	Elutia Inc
20/09/2023	09:30	GlobeNewswire Inc.	Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference	NASDAQ:ELUT	Elutia Inc
19/09/2023	09:36	GlobeNewswire Inc.	Elutia Announces Private Placement for Proceeds Up to $26 Million	NASDAQ:ELUT	Elutia Inc
18/09/2023	17:08	GlobeNewswire Inc.	Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million	NASDAQ:ELUT	Elutia Inc
08/09/2023	09:30	GlobeNewswire Inc.	Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:ELUT	Elutia Inc
06/09/2023	17:05	GlobeNewswire Inc.	Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices	NASDAQ:ELUT	Elutia Inc